Meet the CEO
#InnovativeMinds
Have you ever wondered why a flower is alive while a stone isn't? Dr. 何正宏Jeng Her, the founder and CEO of AP Biosciences, has explored this question by transitioning from physics to life sciences.
Having lived in the United States for over 25 years, Dr. Her gained spearheaded experience in the development of #antibody drugs, leading to the creation of AP Biosciences in Taiwan ????????. Under his leadership, AP Biosciences has pioneered bispecific antibody therapy, focusing on novel treatments for various diseases. He emphasizes a commitment to innovation, stating, "We don't engage in 'Me too' research."
Their latest achievement, IBI302, a dual-function recombinant protein designed to treat wet age-related macular degeneration (#nAMD), has shown promising results in clinical trials in China.
"Taking one more step can be challenging, but success is closer than you think."
Dr. Her's inspirational journey showcases his unwavering determination to push boundaries and drive innovation in #biopharmaceuticals. Read more about his incredible story here: https://lnkd.in/gM_qxBff
Don't forget to visit #Globalbio for more inspiring stories.
Meet the CEO: Dr. Jeng Her, the founder and CEO of AP Biosciences
撰文GlobalBio & Investment
日期2024-04-30
![](/upload/article/_images/1712150544294.jpg)
Meet the CEO: Dr. Jeng Her, the founder and CEO of AP Biosciences